MedPath

Comparative study of two types of steroids for severe COVID disease

Not Applicable
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2021/03/031614
Lead Sponsor
VMMC AND Safdarjung HospitalDelhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All RT-PCR confirmed COVID 19 positive patients severe COVID-19 disease,

who have received steroid therapy (methylprednisolone or dexamethasone)

Exclusion Criteria

1.Patients on chronic steroid therapy

2.Patients having Cushing syndrome

3.Patients on chemotherapy or immunosuppressive drugs

4.Post-operative patients

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath